LAURA NASRALLAH: Open Payments
NPI 1558978569 · BEDFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,762 in 62 payments from 30 companies in 2025. Trend: 2023 $455 · 2024 $1,405 · 2025 $1,762
Food & beverage: $1,637Education: $125
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $277 |
| AstraZeneca Pharmaceuticals LP | 6 | $195 |
| SERVIER PHARMACEUTICALS LLC | 5 | $126 |
| Stemline Therapeutics Inc. | 1 | $109 |
| Daiichi Sankyo Inc. | 3 | $102 |
| PharmaEssentia USA Corporation | 3 | $97 |
| Novartis Pharmaceuticals Corporation | 3 | $85 |
| GENZYME CORPORATION | 3 | $80 |
| Incyte Corporation | 4 | $78 |
| Celgene Corporation | 3 | $67 |
Products named: RYBREVANT, LYNPARZA, ELZONRIS, Enhertu, BESREMI, Tibsovo, REBLOZYL, Fabhalta.
Industry payments across TX — which companies pay providers there.
